Cell-free DNA fragment patterns in early pregnancy may help predict adverse outcomes in patients with immune-mediated ...
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...
The Chosun Ilbo on MSN
No colonoscopy needed: Simple blood test catches 90% of colorectal cancers
A new diagnostic method has been proposed to detect colorectal cancer through blood tests alone, eliminating the need for ...
Recent studies in this field have indicated microbial cell-free DNA (mcfDNA) testing as a viable assay capable of identifying pathogens from the bloodstream. However, this technique has not been ...
BillionToOne’s cell-free DNA testing provides new evidence supporting routine use of cfDNA fetal risk assessment in general-risk pregnancies: Menlo Park, California Thursday, Au ...
Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients for ...
Exploratory analyses of immune reconstitution biomarkers from a Ph1b study of an investigational, oral, live biotherapeutic, SER-155, in adult allo-HCT. The impact of the use of hypomethylating agents ...
Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Speed is a critical differentiator in therapeutic development. For teams developing DNA and RNA therapeutics, non-viral gene therapies, viral vectors, cell-free protein synthesis workflows, or CRISPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results